The article is a review of current knowledge in the field of positron emission tomography and breast cancer diagnostics. It presents in a comprehensive way the physiological background of (18F) fluorodeoxyglucose (FDG) use in the diagnostics. The paper presents FDG study rules. The author discusses the indications for the PET studies in the field of breast cancer diagnostics, the current knowledge and some present prospects of PET development.
Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa